179 related articles for article (PubMed ID: 28695986)
1. Acute heart failure as a result of granulomatous myocarditis: case report on a patient with metastatic melanoma treated with dabrafenib and trametinib.
Winkler JK; Buder-Bakhaya K; Ellert E; Herpel E; Martens UM; Enk A; Hassel JC
J Eur Acad Dermatol Venereol; 2018 Jan; 32(1):e31-e32. PubMed ID: 28695986
[No Abstract] [Full Text] [Related]
2. Bilateral Ischemic Retinal Vasculitis in Metastatic Cutaneous Melanoma Patient Treated with Dabrafenib and Trametinib: A Case Report.
Niro A; Recchimurzo N; Sborgia A; Guida M; Alessio G
Ocul Immunol Inflamm; 2018; 26(5):783-785. PubMed ID: 27973971
[No Abstract] [Full Text] [Related]
3. Hepatic hemorrhage as a consequence of rapid response to combined targeted therapy in metastatic melanoma.
Flaherty DC; Hoffner BW; Lau BJ; Hamid O; Faries MB
J Surg Oncol; 2015 Dec; 112(8):844-5. PubMed ID: 26503563
[TBL] [Abstract][Full Text] [Related]
4. Myasthenia gravis following dabrafenib and trametinib for metastatic melanoma.
Zaloum A; Falet JR; Elkrief A; Chalk C
Neurology; 2020 Feb; 94(7):322-323. PubMed ID: 31888971
[No Abstract] [Full Text] [Related]
5. Pyoderma Gangrenosum Under Dabrafenib and Trametinib for Metastatic Melanoma.
Saint-Jean M; Le Moigne M; Daguze J; Bossard C; Peuvrel L; Quéreux G; Dréno B
Acta Derm Venereol; 2018 Apr; 98(5):530-531. PubMed ID: 29362816
[No Abstract] [Full Text] [Related]
6. Acute intraventricular conduction disorder due to combination therapy with dabrafenib and trametinib for metastatic melanoma: Case report.
Yamamura K; Matsushita S; Aoki M; Kusumoto K
J Dermatol; 2018 May; 45(5):e120-e121. PubMed ID: 29178523
[No Abstract] [Full Text] [Related]
7. Pomalidomide, dabrafenib mesylate, and trametinib dimethyl sulfoxide.
Hussar DA; Kaminski JL
J Am Pharm Assoc (2003); 2013; 53(5):550-8. PubMed ID: 24030134
[No Abstract] [Full Text] [Related]
8. Potassium iodide in successful treatment of erythema nodosum-like lesions induced by combination therapy with dabrafenib and trametinib.
Sawada H; Kanehisa F; Katoh N; Asai J
J Dermatol; 2020 Jan; 47(1):e7-e8. PubMed ID: 31587335
[No Abstract] [Full Text] [Related]
9. Posterior reversible encephalopathy syndrome in a melanoma patient with dabrafenib and trametinib treatment following immunotherapy.
Stefanou MI; Gepfner-Tuma I; Brendle C; Kowarik M; Meiwes A; Eigentler T; Müller A; Garbe C; Ziemann U; Tabatabai G; Forschner A
J Dtsch Dermatol Ges; 2020 Feb; 18(2):136-139. PubMed ID: 31814289
[No Abstract] [Full Text] [Related]
10. Hair and nail adverse events during treatment with targeted therapies for metastatic melanoma.
Dika E; Patrizi A; Ribero S; Fanti PA; Starace M; Melotti B; Sperandi F; Piraccini BM
Eur J Dermatol; 2016 Jun; 26(3):232-9. PubMed ID: 27019511
[TBL] [Abstract][Full Text] [Related]
11. Severe gastrointestinal toxicity with administration of trametinib in combination with dabrafenib and ipilimumab.
Minor DR; Puzanov I; Callahan MK; Hug BA; Hoos A
Pigment Cell Melanoma Res; 2015 Sep; 28(5):611-2. PubMed ID: 25996827
[No Abstract] [Full Text] [Related]
12. Fatherhood during dabrafenib and trametinib therapy for metastatic melanoma.
Cocorocchio E; Pala L; Battaglia A; Gandini S; Peccatori FA; Ferrucci PF
Acta Oncol; 2018 Aug; 57(8):1131-1133. PubMed ID: 29526130
[No Abstract] [Full Text] [Related]
13. Pyrexia by COVID-19 in a patient treated with dabrafenib/trametinib therapy.
Hashimoto H; Ito T; Ide T; Sasaki N; Hikichi S; Furue M
J Dermatol; 2021 Feb; 48(2):e122-e123. PubMed ID: 33200424
[No Abstract] [Full Text] [Related]
14. Case of deep vein thrombosis in a patient with advanced malignant melanoma treated with dabrafenib and trametinib.
Wada N; Uchi H; Furue M
J Dermatol; 2018 Jul; 45(7):e173-e174. PubMed ID: 29430699
[No Abstract] [Full Text] [Related]
15. Prospective Case Series of Cutaneous Adverse Effects Associated With Dabrafenib and Trametinib.
Lacroix JP; Wang B
J Cutan Med Surg; 2017; 21(1):54-59. PubMed ID: 27624900
[TBL] [Abstract][Full Text] [Related]
16. Apparent darkening of scalp hair related to pili multigemini Following dabrafenib and trametinib.
Avila C; Hoffman K; Milani-Nejad N; Pootrakul L
Dermatol Online J; 2020 Jan; 26(1):. PubMed ID: 32155032
[TBL] [Abstract][Full Text] [Related]
17. [Development of serous retinopathy during therapy of a metastatic cutaneous melanoma].
Lüdeke I; Terheyden P; Grisanti S; Lüke M
Ophthalmologe; 2016 Oct; 113(10):861-863. PubMed ID: 26873702
[TBL] [Abstract][Full Text] [Related]
18. BRAF Signaling Pathway Inhibition, Podocyte Injury, and Nephrotic Syndrome.
Perico L; Mandalà M; Schieppati A; Carrara C; Rizzo P; Conti S; Longaretti L; Benigni A; Remuzzi G
Am J Kidney Dis; 2017 Jul; 70(1):145-150. PubMed ID: 28242136
[TBL] [Abstract][Full Text] [Related]
19. Granulomatous nephritis and dermatitis in a patient with BRAF V600E mutant metastatic melanoma treated with dabrafenib and trametinib.
Jansen YJ; Janssens P; Hoorens A; Schreuer MS; Seremet T; Wilgenhof S; Neyns B
Melanoma Res; 2015 Dec; 25(6):550-4. PubMed ID: 26512791
[TBL] [Abstract][Full Text] [Related]
20. Comparison of dabrafenib and trametinib combination therapy with vemurafenib monotherapy on health-related quality of life in patients with unresectable or metastatic cutaneous BRAF Val600-mutation-positive melanoma (COMBI-v): results of a phase 3, open-label, randomised trial.
Grob JJ; Amonkar MM; Karaszewska B; Schachter J; Dummer R; Mackiewicz A; Stroyakovskiy D; Drucis K; Grange F; Chiarion-Sileni V; Rutkowski P; Lichinitser M; Levchenko E; Wolter P; Hauschild A; Long GV; Nathan P; Ribas A; Flaherty K; Sun P; Legos JJ; McDowell DO; Mookerjee B; Schadendorf D; Robert C
Lancet Oncol; 2015 Oct; 16(13):1389-98. PubMed ID: 26433819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]